Talkspace, Inc. (TALK) Stock Competitors & Peer Comparison
See (TALK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TALK | $5.21 | -0.19% | 872.7M | 130.25 | $0.04 | N/A |
| HCA | $361.71 | -1.54% | 80.6B | 12.51 | $29.03 | +0.81% |
| THC | $161.62 | -1.21% | 14.2B | 8.56 | $19.24 | N/A |
| SOLV | $81.09 | +6.10% | 13.6B | 9.59 | $8.17 | N/A |
| DVA | $192.66 | +2.54% | 12.5B | 18.80 | $10.38 | N/A |
| FMS | $21.80 | +6.06% | 11.2B | 11.00 | $1.90 | +4.13% |
| EHC | $100.56 | -0.97% | 10.2B | 17.66 | $5.84 | +0.72% |
| ENSG | $164.07 | -0.98% | 9.7B | 27.10 | $6.15 | +0.16% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| UHS | $143.52 | +0.68% | 9.1B | 6.09 | $23.95 | +0.55% |
Stock Comparison
TALK vs HCA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, HCA has a market cap of 80.6B. Regarding current trading prices, TALK is priced at $5.21, while HCA trades at $361.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas HCA's P/E ratio is 12.51. In terms of profitability, TALK's ROE is +0.01%, compared to HCA's ROE of -1.23%. Regarding short-term risk, TALK is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check HCA's competition here
TALK vs THC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, THC has a market cap of 14.2B. Regarding current trading prices, TALK is priced at $5.21, while THC trades at $161.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas THC's P/E ratio is 8.56. In terms of profitability, TALK's ROE is +0.01%, compared to THC's ROE of +0.41%. Regarding short-term risk, TALK is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check THC's competition here
TALK vs SOLV Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SOLV has a market cap of 13.6B. Regarding current trading prices, TALK is priced at $5.21, while SOLV trades at $81.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SOLV's P/E ratio is 9.59. In terms of profitability, TALK's ROE is +0.01%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, TALK is less volatile compared to SOLV. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SOLV's competition here
TALK vs DVA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, DVA has a market cap of 12.5B. Regarding current trading prices, TALK is priced at $5.21, while DVA trades at $192.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas DVA's P/E ratio is 18.80. In terms of profitability, TALK's ROE is +0.01%, compared to DVA's ROE of -1.33%. Regarding short-term risk, TALK is less volatile compared to DVA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check DVA's competition here
TALK vs FMS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, FMS has a market cap of 11.2B. Regarding current trading prices, TALK is priced at $5.21, while FMS trades at $21.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas FMS's P/E ratio is 11.00. In terms of profitability, TALK's ROE is +0.01%, compared to FMS's ROE of +0.07%. Regarding short-term risk, TALK is less volatile compared to FMS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check FMS's competition here
TALK vs EHC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, EHC has a market cap of 10.2B. Regarding current trading prices, TALK is priced at $5.21, while EHC trades at $100.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas EHC's P/E ratio is 17.66. In terms of profitability, TALK's ROE is +0.01%, compared to EHC's ROE of +0.25%. Regarding short-term risk, TALK is less volatile compared to EHC. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check EHC's competition here
TALK vs ENSG Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ENSG has a market cap of 9.7B. Regarding current trading prices, TALK is priced at $5.21, while ENSG trades at $164.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ENSG's P/E ratio is 27.10. In terms of profitability, TALK's ROE is +0.01%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, TALK is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ENSG's competition here
TALK vs OSH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, TALK is priced at $5.21, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas OSH's P/E ratio is -17.65. In terms of profitability, TALK's ROE is +0.01%, compared to OSH's ROE of +4.64%. Regarding short-term risk, TALK is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check OSH's competition here
TALK vs UHS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, UHS has a market cap of 9.1B. Regarding current trading prices, TALK is priced at $5.21, while UHS trades at $143.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas UHS's P/E ratio is 6.09. In terms of profitability, TALK's ROE is +0.01%, compared to UHS's ROE of +0.21%. Regarding short-term risk, TALK is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check UHS's competition here
TALK vs CHE Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CHE has a market cap of 5.7B. Regarding current trading prices, TALK is priced at $5.21, while CHE trades at $431.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CHE's P/E ratio is 23.29. In terms of profitability, TALK's ROE is +0.01%, compared to CHE's ROE of +0.25%. Regarding short-term risk, TALK is less volatile compared to CHE. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CHE's competition here
TALK vs LHCG Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, TALK is priced at $5.21, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas LHCG's P/E ratio is 82.83. In terms of profitability, TALK's ROE is +0.01%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, TALK is less volatile compared to LHCG. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check LHCG's competition here
TALK vs MMED Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, MMED has a market cap of 4.1B. Regarding current trading prices, TALK is priced at $5.21, while MMED trades at $14.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas MMED's P/E ratio is -11.40. In terms of profitability, TALK's ROE is +0.01%, compared to MMED's ROE of -0.09%. Regarding short-term risk, TALK is less volatile compared to MMED. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check MMED's competition here
TALK vs AMED Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, TALK is priced at $5.21, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AMED's P/E ratio is 39.30. In terms of profitability, TALK's ROE is +0.01%, compared to AMED's ROE of +0.09%. Regarding short-term risk, TALK is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check AMED's competition here
TALK vs OPCH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, OPCH has a market cap of 3.2B. Regarding current trading prices, TALK is priced at $5.21, while OPCH trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas OPCH's P/E ratio is 16.04. In terms of profitability, TALK's ROE is +0.01%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, TALK is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check OPCH's competition here
TALK vs BKD Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, TALK is priced at $5.21, while BKD trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas BKD's P/E ratio is -14.07. In terms of profitability, TALK's ROE is +0.01%, compared to BKD's ROE of +401.19%. Regarding short-term risk, TALK is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check BKD's competition here
TALK vs NHC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NHC has a market cap of 2.9B. Regarding current trading prices, TALK is priced at $5.21, while NHC trades at $186.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NHC's P/E ratio is 23.72. In terms of profitability, TALK's ROE is +0.01%, compared to NHC's ROE of +0.12%. Regarding short-term risk, TALK is less volatile compared to NHC. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NHC's competition here
TALK vs LFST Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, LFST has a market cap of 2.9B. Regarding current trading prices, TALK is priced at $5.21, while LFST trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas LFST's P/E ratio is 125.00. In terms of profitability, TALK's ROE is +0.01%, compared to LFST's ROE of +0.02%. Regarding short-term risk, TALK is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check LFST's competition here
TALK vs ACHC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ACHC has a market cap of 2.4B. Regarding current trading prices, TALK is priced at $5.21, while ACHC trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ACHC's P/E ratio is -2.11. In terms of profitability, TALK's ROE is +0.01%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, TALK is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ACHC's competition here
TALK vs SEM Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, TALK is priced at $5.21, while SEM trades at $16.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SEM's P/E ratio is 15.41. In terms of profitability, TALK's ROE is +0.01%, compared to SEM's ROE of +0.08%. Regarding short-term risk, TALK is less volatile compared to SEM. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SEM's competition here
TALK vs AMEH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.21, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AMEH's P/E ratio is 39.25. In terms of profitability, TALK's ROE is +0.01%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, TALK is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AMEH's competition here
TALK vs ASTH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.21, while ASTH trades at $37.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ASTH's P/E ratio is 60.16. In terms of profitability, TALK's ROE is +0.01%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, TALK is less volatile compared to ASTH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ASTH's competition here
TALK vs MD Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, MD has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.21, while MD trades at $22.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas MD's P/E ratio is 10.60. In terms of profitability, TALK's ROE is +0.01%, compared to MD's ROE of +0.20%. Regarding short-term risk, TALK is less volatile compared to MD. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check MD's competition here
TALK vs SGRY Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, TALK is priced at $5.21, while SGRY trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SGRY's P/E ratio is -22.90. In terms of profitability, TALK's ROE is +0.01%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, TALK is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SGRY's competition here
TALK vs ADUS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ADUS has a market cap of 1.7B. Regarding current trading prices, TALK is priced at $5.21, while ADUS trades at $89.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ADUS's P/E ratio is 16.33. In terms of profitability, TALK's ROE is +0.01%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, TALK is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ADUS's competition here
TALK vs AVAH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AVAH has a market cap of 1.5B. Regarding current trading prices, TALK is priced at $5.21, while AVAH trades at $6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AVAH's P/E ratio is 5.60. In terms of profitability, TALK's ROE is +0.01%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, TALK is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AVAH's competition here
TALK vs HCSG Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, TALK is priced at $5.21, while HCSG trades at $20.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas HCSG's P/E ratio is 21.25. In terms of profitability, TALK's ROE is +0.01%, compared to HCSG's ROE of +0.14%. Regarding short-term risk, TALK is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check HCSG's competition here
TALK vs AGL Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AGL has a market cap of 1.4B. Regarding current trading prices, TALK is priced at $5.21, while AGL trades at $95.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AGL's P/E ratio is -3.66. In terms of profitability, TALK's ROE is +0.01%, compared to AGL's ROE of -1.46%. Regarding short-term risk, TALK is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AGL's competition here
TALK vs BKDT Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, TALK is priced at $5.21, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas BKDT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, TALK is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check BKDT's competition here
TALK vs CMPS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CMPS has a market cap of 1.2B. Regarding current trading prices, TALK is priced at $5.21, while CMPS trades at $13.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CMPS's P/E ratio is -4.04. In terms of profitability, TALK's ROE is +0.01%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, TALK is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CMPS's competition here
TALK vs AMN Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AMN has a market cap of 1.2B. Regarding current trading prices, TALK is priced at $5.21, while AMN trades at $30.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AMN's P/E ratio is -35.25. In terms of profitability, TALK's ROE is +0.01%, compared to AMN's ROE of -0.05%. Regarding short-term risk, TALK is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AMN's competition here
TALK vs ARDT Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ARDT has a market cap of 1.1B. Regarding current trading prices, TALK is priced at $5.21, while ARDT trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ARDT's P/E ratio is 8.21. In terms of profitability, TALK's ROE is +0.01%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, TALK is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ARDT's competition here
TALK vs PNTG Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, PNTG has a market cap of 1.1B. Regarding current trading prices, TALK is priced at $5.21, while PNTG trades at $30.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas PNTG's P/E ratio is 35.29. In terms of profitability, TALK's ROE is +0.01%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, TALK is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check PNTG's competition here
TALK vs INNV Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, INNV has a market cap of 961M. Regarding current trading prices, TALK is priced at $5.21, while INNV trades at $7.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas INNV's P/E ratio is -88.50. In terms of profitability, TALK's ROE is +0.01%, compared to INNV's ROE of -0.09%. Regarding short-term risk, TALK is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check INNV's competition here
TALK vs USPH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, USPH has a market cap of 943.3M. Regarding current trading prices, TALK is priced at $5.21, while USPH trades at $61.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas USPH's P/E ratio is 123.96. In terms of profitability, TALK's ROE is +0.01%, compared to USPH's ROE of +0.00%. Regarding short-term risk, TALK is less volatile compared to USPH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check USPH's competition here
TALK vs FSHCX Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, FSHCX has a market cap of 820.5M. Regarding current trading prices, TALK is priced at $5.21, while FSHCX trades at $105.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas FSHCX's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to FSHCX's ROE of N/A. Regarding short-term risk, TALK is more volatile compared to FSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check FSHCX's competition here
TALK vs EHAB Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, TALK is priced at $5.21, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas EHAB's P/E ratio is -197.14. In terms of profitability, TALK's ROE is +0.01%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, TALK is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check EHAB's competition here
TALK vs SNDA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SNDA has a market cap of 671.8M. Regarding current trading prices, TALK is priced at $5.21, while SNDA trades at $33.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SNDA's P/E ratio is -5.75. In terms of profitability, TALK's ROE is +0.01%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, TALK is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SNDA's competition here
TALK vs GMRS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, GMRS has a market cap of 496.4M. Regarding current trading prices, TALK is priced at $5.21, while GMRS trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas GMRS's P/E ratio is 5.64. In terms of profitability, TALK's ROE is +0.01%, compared to GMRS's ROE of N/A. Regarding short-term risk, TALK is less volatile compared to GMRS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check GMRS's competition here
TALK vs MCTA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, TALK is priced at $5.21, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas MCTA's P/E ratio is 419.36. In terms of profitability, TALK's ROE is +0.01%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, TALK is more volatile compared to MCTA. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check MCTA's competition here
TALK vs CCRN Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CCRN has a market cap of 424.2M. Regarding current trading prices, TALK is priced at $5.21, while CCRN trades at $13.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CCRN's P/E ratio is -4.30. In terms of profitability, TALK's ROE is +0.01%, compared to CCRN's ROE of -0.27%. Regarding short-term risk, TALK is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CCRN's competition here
TALK vs TOI Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TOI has a market cap of 422.9M. Regarding current trading prices, TALK is priced at $5.21, while TOI trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TOI's P/E ratio is -12.09. In terms of profitability, TALK's ROE is +0.01%, compared to TOI's ROE of +3.27%. Regarding short-term risk, TALK is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check TOI's competition here
TALK vs CYH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CYH has a market cap of 394.6M. Regarding current trading prices, TALK is priced at $5.21, while CYH trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CYH's P/E ratio is 0.81. In terms of profitability, TALK's ROE is +0.01%, compared to CYH's ROE of +0.06%. Regarding short-term risk, TALK is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CYH's competition here
TALK vs AIRS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AIRS has a market cap of 364.7M. Regarding current trading prices, TALK is priced at $5.21, while AIRS trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AIRS's P/E ratio is -30.41. In terms of profitability, TALK's ROE is +0.01%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, TALK is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AIRS's competition here
TALK vs AUNA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AUNA has a market cap of 332.4M. Regarding current trading prices, TALK is priced at $5.21, while AUNA trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AUNA's P/E ratio is 16.63. In terms of profitability, TALK's ROE is +0.01%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, TALK is less volatile compared to AUNA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AUNA's competition here
TALK vs AONC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AONC has a market cap of 292.5M. Regarding current trading prices, TALK is priced at $5.21, while AONC trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AONC's P/E ratio is -11.24. In terms of profitability, TALK's ROE is +0.01%, compared to AONC's ROE of +0.06%. Regarding short-term risk, TALK is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check AONC's competition here
TALK vs CSU Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, TALK is priced at $5.21, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CSU's P/E ratio is 0.67. In terms of profitability, TALK's ROE is +0.01%, compared to CSU's ROE of -0.51%. Regarding short-term risk, TALK is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CSU's competition here
TALK vs JYNT Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, JYNT has a market cap of 117.9M. Regarding current trading prices, TALK is priced at $5.21, while JYNT trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas JYNT's P/E ratio is 91.89. In terms of profitability, TALK's ROE is +0.01%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, TALK is less volatile compared to JYNT. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check JYNT's competition here
TALK vs NAKAW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NAKAW has a market cap of 116.4M. Regarding current trading prices, TALK is priced at $5.21, while NAKAW trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NAKAW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, TALK is less volatile compared to NAKAW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NAKAW's competition here
TALK vs FVE Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, TALK is priced at $5.21, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas FVE's P/E ratio is -5.64. In terms of profitability, TALK's ROE is +0.01%, compared to FVE's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check FVE's competition here
TALK vs KDLYW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, TALK is priced at $5.21, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas KDLYW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, TALK is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check KDLYW's competition here
TALK vs BTMD Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, BTMD has a market cap of 93.1M. Regarding current trading prices, TALK is priced at $5.21, while BTMD trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas BTMD's P/E ratio is 4.91. In terms of profitability, TALK's ROE is +0.01%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, TALK is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check BTMD's competition here
TALK vs DCGO Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, DCGO has a market cap of 56.7M. Regarding current trading prices, TALK is priced at $5.21, while DCGO trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas DCGO's P/E ratio is -0.30. In terms of profitability, TALK's ROE is +0.01%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, TALK is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check DCGO's competition here
TALK vs ALR Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, TALK is priced at $5.21, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ALR's P/E ratio is -1.11. In terms of profitability, TALK's ROE is +0.01%, compared to ALR's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to ALR. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ALR's competition here
TALK vs PIII Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, PIII has a market cap of 33.1M. Regarding current trading prices, TALK is priced at $5.21, while PIII trades at $10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas PIII's P/E ratio is -0.26. In terms of profitability, TALK's ROE is +0.01%, compared to PIII's ROE of +1.85%. Regarding short-term risk, TALK is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check PIII's competition here
TALK vs IMAC Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, TALK is priced at $5.21, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas IMAC's P/E ratio is -2.27. In terms of profitability, TALK's ROE is +0.01%, compared to IMAC's ROE of +1183.61%. Regarding short-term risk, TALK is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check IMAC's competition here
TALK vs CCEL Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CCEL has a market cap of 27.8M. Regarding current trading prices, TALK is priced at $5.21, while CCEL trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CCEL's P/E ratio is -10.78. In terms of profitability, TALK's ROE is +0.01%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, TALK is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check CCEL's competition here
TALK vs CANO-WT Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, TALK is priced at $5.21, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, TALK is less volatile compared to CANO-WT. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CANO-WT's competition here
TALK vs AIH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, TALK is priced at $5.21, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AIH's P/E ratio is -2.78. In terms of profitability, TALK's ROE is +0.01%, compared to AIH's ROE of +1.16%. Regarding short-term risk, TALK is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AIH's competition here
TALK vs CANO Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, TALK is priced at $5.21, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CANO's P/E ratio is -0.01. In terms of profitability, TALK's ROE is +0.01%, compared to CANO's ROE of -1.49%. Regarding short-term risk, TALK is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CANO's competition here
TALK vs FTRP Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, TALK is priced at $5.21, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas FTRP's P/E ratio is -1.22. In terms of profitability, TALK's ROE is +0.01%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, TALK is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check FTRP's competition here
TALK vs AMS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AMS has a market cap of 9.2M. Regarding current trading prices, TALK is priced at $5.21, while AMS trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AMS's P/E ratio is -6.30. In terms of profitability, TALK's ROE is +0.01%, compared to AMS's ROE of -0.06%. Regarding short-term risk, TALK is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AMS's competition here
TALK vs MODV Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, TALK is priced at $5.21, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas MODV's P/E ratio is -0.03. In terms of profitability, TALK's ROE is +0.01%, compared to MODV's ROE of +1.84%. Regarding short-term risk, TALK is more volatile compared to MODV. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check MODV's competition here
TALK vs GBNH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, TALK is priced at $5.21, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas GBNH's P/E ratio is -0.06. In terms of profitability, TALK's ROE is +0.01%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, TALK is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check GBNH's competition here
TALK vs SYRA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SYRA has a market cap of 5.4M. Regarding current trading prices, TALK is priced at $5.21, while SYRA trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SYRA's P/E ratio is -24.00. In terms of profitability, TALK's ROE is +0.01%, compared to SYRA's ROE of -0.08%. Regarding short-term risk, TALK is less volatile compared to SYRA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SYRA's competition here
TALK vs TOIIW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TOIIW has a market cap of 5.4M. Regarding current trading prices, TALK is priced at $5.21, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TOIIW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, TALK is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check TOIIW's competition here
TALK vs RHE-PA Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, TALK is priced at $5.21, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, TALK's ROE is +0.01%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, TALK is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check RHE-PA's competition here
TALK vs RHE Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, TALK is priced at $5.21, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas RHE's P/E ratio is -1.79. In terms of profitability, TALK's ROE is +0.01%, compared to RHE's ROE of -0.36%. Regarding short-term risk, TALK is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check RHE's competition here
TALK vs ATIP Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, TALK is priced at $5.21, while ATIP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ATIP's P/E ratio is -0.03. In terms of profitability, TALK's ROE is +0.01%, compared to ATIP's ROE of +2.05%. Regarding short-term risk, TALK is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ATIP's competition here
TALK vs IMACW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, TALK is priced at $5.21, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas IMACW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to IMACW's ROE of +1.05%. Regarding short-term risk, TALK is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check IMACW's competition here
TALK vs TALKW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TALKW has a market cap of 770.6K. Regarding current trading prices, TALK is priced at $5.21, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TALKW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, TALK is more volatile compared to TALKW. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check TALKW's competition here
TALK vs CCM Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, CCM has a market cap of 656K. Regarding current trading prices, TALK is priced at $5.21, while CCM trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas CCM's P/E ratio is -1.43. In terms of profitability, TALK's ROE is +0.01%, compared to CCM's ROE of +0.07%. Regarding short-term risk, TALK is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check CCM's competition here
TALK vs MNDR Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, MNDR has a market cap of 640.4K. Regarding current trading prices, TALK is priced at $5.21, while MNDR trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas MNDR's P/E ratio is -0.30. In terms of profitability, TALK's ROE is +0.01%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check MNDR's competition here
TALK vs NIVF Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NIVF has a market cap of 480.1K. Regarding current trading prices, TALK is priced at $5.21, while NIVF trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NIVF's P/E ratio is 0.02. In terms of profitability, TALK's ROE is +0.01%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, TALK is less volatile compared to NIVF. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NIVF's competition here
TALK vs NVOS Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NVOS has a market cap of 394.6K. Regarding current trading prices, TALK is priced at $5.21, while NVOS trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NVOS's P/E ratio is -0.02. In terms of profitability, TALK's ROE is +0.01%, compared to NVOS's ROE of -0.81%. Regarding short-term risk, TALK is less volatile compared to NVOS. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NVOS's competition here
TALK vs BACK Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, BACK has a market cap of 151.4K. Regarding current trading prices, TALK is priced at $5.21, while BACK trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas BACK's P/E ratio is -0.01. In terms of profitability, TALK's ROE is +0.01%, compared to BACK's ROE of +1.05%. Regarding short-term risk, TALK is less volatile compared to BACK. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check BACK's competition here
TALK vs PIIIW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, PIIIW has a market cap of 50K. Regarding current trading prices, TALK is priced at $5.21, while PIIIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, TALK's ROE is +0.01%, compared to PIIIW's ROE of +1.85%. Regarding short-term risk, TALK is more volatile compared to PIIIW. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check PIIIW's competition here
TALK vs NIVFW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, TALK is priced at $5.21, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NIVFW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, TALK is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NIVFW's competition here
TALK vs IONM Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, IONM has a market cap of 313. Regarding current trading prices, TALK is priced at $5.21, while IONM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas IONM's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to IONM's ROE of +5.28%. Regarding short-term risk, TALK is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check IONM's competition here
TALK vs KND Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, KND has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas KND's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to KND's ROE of -0.53%. Regarding short-term risk, TALK is less volatile compared to KND. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check KND's competition here
TALK vs TVTY Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TVTY's P/E ratio is 19.06. In terms of profitability, TALK's ROE is +0.01%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, TALK is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check TVTY's competition here
TALK vs DCGOW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas DCGOW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, TALK is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check DCGOW's competition here
TALK vs NFH Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, NFH has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas NFH's P/E ratio is -19.75. In terms of profitability, TALK's ROE is +0.01%, compared to NFH's ROE of -0.06%. Regarding short-term risk, TALK is less volatile compared to NFH. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check NFH's competition here
TALK vs HNGR Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas HNGR's P/E ratio is 19.71. In terms of profitability, TALK's ROE is +0.01%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, TALK is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check HNGR's competition here
TALK vs AFAM Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas AFAM's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, TALK is less volatile compared to AFAM. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check AFAM's competition here
TALK vs SLHGP Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, TALK's ROE is +0.01%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, TALK is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for TALK.Check SLHGP's competition here
TALK vs TLMD Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TLMD's P/E ratio is -1.60. In terms of profitability, TALK's ROE is +0.01%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to TLMD. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check TLMD's competition here
TALK vs SLHG Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas SLHG's P/E ratio is -1.48. In terms of profitability, TALK's ROE is +0.01%, compared to SLHG's ROE of N/A. Regarding short-term risk, TALK is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check SLHG's competition here
TALK vs DVCR Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas DVCR's P/E ratio is 28.34. In terms of profitability, TALK's ROE is +0.01%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, TALK is less volatile compared to DVCR. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check DVCR's competition here
TALK vs ATIP-WT Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, TALK is less volatile compared to ATIP-WT. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check ATIP-WT's competition here
TALK vs TLMDW Comparison June 2026
TALK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TALK stands at 872.7M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, TALK is priced at $5.21, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TALK currently has a P/E ratio of 130.25, whereas TLMDW's P/E ratio is N/A. In terms of profitability, TALK's ROE is +0.01%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, TALK is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for TALK.Check TLMDW's competition here